Back to 
Royal Bank of Canada
Royal Bank of Canada
TRIB
2 quarters
Position history for Royal Bank of Canada's holdings in Trinity Biotech plc
No. Royal Bank of Canada exited its TRIB (Trinity Biotech) position in Q1 2026. Its Q4 2025 13F listed 1,000 shares worth $1,000. Royal Bank of Canada first reported TRIB in Q4 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$1,000
Total Shares Change
-1,000
Quarter-by-Quarter History